Asked by: Karl McCartney (Conservative - Lincoln)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of publishing a Men's Health Strategy.
Answered by Neil O'Brien
No assessment has been made. However, the Government is taking action to address conditions that affect men, including suicide, heart disease, cancer and associated risk factors such as smoking. As with other major conditions and drivers of ill health, we consider the impact that each issue has at a population level and the most effective ways to address them, including for the groups most impacted.
Asked by: Karl McCartney (Conservative - Lincoln)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what lessons the Government has learnt from the approach taken to tackling the covid-19 pandemic by Governments in (a) South America, (b) Asia and (c) elsewhere in the world.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
Throughout the pandemic, the Government has maintained regular contact with many other countries, including those in South America and Asia, on a wide range of issues relating to COVID-19. We continue to monitor the outbreak around the world and, guided by the science, we will continue to work with other countries to defeat the virus.
Asked by: Karl McCartney (Conservative - Lincoln)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps his Department has taken to prepare for the UK to leave the EU since 23 June 2016; and what further such steps his Department plans to take in the remainder of 2016.
Answered by David Mowat
The Department for Exiting the European Union has responsibility for overseeing preparations for the withdrawal of the United Kindom from the EU and conducting these withdrawal negotiations in support of the Prime Minister. In doing this it is working very closely with other government departments, including the Department of Health and a wide range of other interested parties.
Asked by: Karl McCartney (Conservative - Lincoln)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what recent discussions he has had with (a) his ministerial colleagues and (b) external organisations on the provision of free prescriptions for those over the age of 60 who are in full-time employment.
Answered by Alistair Burt
We have had not had recent discussions at Ministerial level or with external organisations on changing the entitlement to free prescriptions for those age 60 and over who are in full time employment.
Asked by: Karl McCartney (Conservative - Lincoln)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what financial contributions the Government has made to the Lincolnshire Integrated Voluntary Emergency Service (a) in total for each of the last five years that figures are available and (b) for the provision of drugs.
Answered by Ben Gummer
The Government has not made any direct financial contributions to the Lincolnshire Integrated Voluntary Emergency Service (LIVES).
NHS England advises that Lincolnshire West Clinical Commissioning Group (CCG) is the lead National Health Service commissioner for LIVES. It commissions services through a block contract on a capitation basis and does not collect information about LIVES’ spending on the provision of drugs. The following table shows the amount the CCG spent on LIVES in the last three years.
Lincolnshire West CCG spending on LIVES, 2013/14 to 2015/16 | |
Year | Total £000 |
2013/14 | 262,000 |
2014/15 | 307,399 |
2015/16 | 302,481 |
Source: Lincolnshire West CCG
Notes: CCGs were established in April 2013, replacing primary care trusts (PCTs). Information is not available about PCT spending on LIVES before April 2013.
Asked by: Karl McCartney (Conservative - Lincoln)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how much the Government spent on prescriptions for people over the age of 60 in full-time employment in each of the last five years that figures are available.
Answered by Alistair Burt
The information is not available as the employment status of patients is not collected.
Asked by: Karl McCartney (Conservative - Lincoln)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how much the Community Pharmacy Contractual Framework has accrued to the public purse through Category M savings since 2005.
Answered by Alistair Burt
The adjustments to Category M generic medicine reimbursement prices that have been made in order to align total community pharmacy funding (including margin earned on the difference between reimbursement prices and purchase prices) with the target amount set for the community pharmacy contractual framework are shown in the table below.
Month | Margin removed (-) or added (+) (quarterly amount on recurrent basis) (£ m) |
April 2005 | -75 |
October 2006 | -75 |
October 2007 | -100 |
October 2008 | -32.5 |
October 2009 | -20 |
October 2010 | -60 |
April 2011 | -22.5 |
October 2011 | -39 |
April 2012 | -10 |
October 2012 | -72.5 |
October 2013 | -20 |
April 2014 | -30 |
October 2014 | +30 |
January 2016 | -45 |
Source: Department of Health
Asked by: Karl McCartney (Conservative - Lincoln)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, whether his Department's risk register assesses risks to (a) the provision of health services and (b) changes in the level of the cost of providing health services which result from immigration from (i) other EEA member states and (ii) countries from outside the EEA; and if he will make a statement.
Answered by Jane Ellison
The Department’s risk management process is used to assess risk across the full range of the Department’s business including the provision of health services and the costs of providing those services.
Asked by: Karl McCartney (Conservative - Lincoln)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what financial impact analysis his Department has conducted on the proposed new model of community pharmacy.
Answered by Alistair Burt
Community pharmacy is a vital part of the National Health Service and can play an even greater role. In the Spending Review, the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020/21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.
The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.
We are consulting the Pharmaceutical Services Negotiating Committee (PSNC) and others, including patient and public representatives, on our proposals for community pharmacy in 2016/17 and beyond. We announced on 16 March 2016 that the consultation period was to be extended to allow more time to develop the proposed changes with the PSNC and others. It will now close on 24 May 2016.
The proposals were considered against the Public Sector Equality Duty and other duties. The consultation responses will inform the final impact assessment, which will be published in due course.
Asked by: Karl McCartney (Conservative - Lincoln)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps his Department took when devising the new model of community pharmacy to take into account both (a) rural and (b) urban deprivation.
Answered by Alistair Burt
Community pharmacy is a vital part of the National Health Service and can play an even greater role. In the Spending Review, the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020/21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.
The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.
We are consulting the Pharmaceutical Services Negotiating Committee (PSNC) and others, including patient and public representatives, on our proposals for community pharmacy in 2016/17 and beyond. We announced on 16 March 2016 that the consultation period was to be extended to allow more time to develop the proposed changes with the PSNC and others. It will now close on 24 May 2016.
The proposals were considered against the Public Sector Equality Duty and other duties. The consultation responses will inform the final impact assessment, which will be published in due course.